Clinical Observation of Maxin Shigan Tang Combined with Tingli Dazao Xiefei Tang as Modified Auxiliary Therapy for Community Acquired Pneumonia in Middle-aged and Old Patients

TAN Ya-yun; LIANG Dong

doi:10.13422/j.cnki.syfjx.2016050202

您当前的位置：

首页 >

文章列表页 >

Clinical Observation of Maxin Shigan Tang Combined with Tingli Dazao Xiefei Tang as Modified Auxiliary Therapy for Community Acquired Pneumonia in Middle-aged and Old Patients

更新时间：2024-01-04

- Clinical Observation of Maxin Shigan Tang Combined with Tingli Dazao Xiefei Tang as Modified Auxiliary Therapy for Community Acquired Pneumonia in Middle-aged and Old Patients
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 22, Issue 5, Pages: 202-205(2016)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2016050202
  CLC： R259
- Published：2016
- 稿件说明：
移动端阅览
TAN Ya-yun, LIANG Dong. Clinical Observation of Maxin Shigan Tang Combined with Tingli Dazao Xiefei Tang as Modified Auxiliary Therapy for Community Acquired Pneumonia in Middle-aged and Old Patients[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(5): 202-205.
DOI：

TAN Ya-yun, LIANG Dong. Clinical Observation of Maxin Shigan Tang Combined with Tingli Dazao Xiefei Tang as Modified Auxiliary Therapy for Community Acquired Pneumonia in Middle-aged and Old Patients[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(5): 202-205. DOI： 10.13422/j.cnki.syfjx.2016050202.

摘要

目的: 观察麻杏石甘汤合葶苈大枣泻肺汤加减辅助治疗社区中老年患者获得性肺炎(CAP)(痰热壅盛证)的疗效及对C-反应蛋白(CRP)

血沉(ESR)

降钙素原(PCT)的影响. 方法: 106例CAP患者采用随机按入院先后分为对照组52和试验组54例.对照组注射用头孢哌酮钠舒巴坦钠

3 g

静脉滴注

2次/d;和注射用阿奇霉素

0.5 g

静脉滴注

1次/d.疗程共14 d.试验组西医处理方法同对照组

并加用麻杏石甘汤合葶苈大枣泻肺汤加减内服

1剂/d.疗程为14 d.记录治疗前后主要临床症状、体征评分;记录发热、咳嗽、咯痰、肺部湿啰音、肺片、血象转归情况和平均住院时间;检测治疗前后CRP

ESR

PCT的变化情况. 结论: 经Ridit分析

试验组临床疗效优于对照组(P<0.05);治疗后试验组主要临床症状、体征(咳嗽、咯痰、黄脓痰、喘息、气短、气急、反应迟钝、湿啰音、痰多、支气管音)评分均低于对照组(P<0.01);治疗后试验组发热、咳嗽、肺部湿啰音消失时间

肺片、血象恢复正常时间和平均住院时间均短于对照组(P<0.05

P<0.01);治疗后试验组CRP

ESR

PCT水平低于对照组(P<0.05

P<0.01). 结论: 麻杏石甘汤合葶苈大枣泻肺汤加减辅助治疗中老年患者社区获得性肺炎能减轻临床症状、体征

缩短病程

降低CRP

ESR

PCT

提高临床疗效.

Abstract

Objective: To observe the clinical efficacy of Maxin Shigan Tang combined with Tingli Dazao Xiefei Tang as modified auxiliary therapy for community acquired pneumonia (CAP) in middle-aged and old patients as well as its effect on C-reactive protein (CRP)

erythrocyte sedimentation rate (ESR) and procalcitonin (PCT). Method: One hundred and six cases patients with CAP were divided into control group (52 cases) and experimental group (54 cases) by random number table. Patients in control group received cefoperazone sodium and sulbactam sodium for intravenous infusion

3 g

2 times/day and azithromycin injection for intravenous infusion

0.5 g

1 time/day

with a treatment course of 14 days in total. Based on the treatment of control group

patients in experimental group added Maxin Shigan Tang combined with Tingli Dazao Xiefei Tang

1 dose/day

with a treatment course of 14 days. Before and after treatment

scores of main symptoms and signs were recorded;fevers

cough

expectoration

lung rale

lung slices

the blood and average stay were recorded. Before and after treatment

levels of CRP

ESR and PCT were detected. Result: In Ridit analysis

clinical effect in experimental group was superior to that in control group (P<0.05). After treatment

scores of the main symptoms and sings (cough

expectoration

sputum

wheeze

breathe hard

flustered and exasperated

lags in response

moist rales

excessive phlegm and bronchophony) were lower than those in control group (P<0.01). After treatment

time of fevers

cough

lung rale

recovery time in lung slices and blood examination as well as the average stay in experimental group were shorter than those in control group (P<0.05

P<0.01). Levels of CRP

ESR and PCT were also lower than those in control group after treatment (P<0.05

P<0.01). Conclusion: Maxin Shigan Tang combined with Tingli Dazao Xiefei Tang can relieve symptoms and signs

shorten courses

reduce levels of CRP

ESR and PCT

and improve clinical effect for the treatment of community acquired pneumonia (CAP) in middle-aged and old patients.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Yuebi Jia Banxiatang on Inflammatory Markers and Prognosis of Patients with Community Acquired Pneumonia in Old People

Clinical Effect of Addition and Subtraction Therapy of Wuhutang Combined with Qingjin Jianghuotang to Community Acquired Pneumonia in Children with Syndrome of Phlegm Heat Closing Lung

Clinical Observation of Maxing Shigan Tang Combined with Weijingtang in Treating Elderly Patients with Aspiration Pneumonia with Phlegm-heat Stagnating

Add and Subtract Therapy of Zhuye Shigao Tang Combined with Qingqi Huatan Pills on Chronic Obstructive Pulmonary Disease at Acute and Aggravating Period

Related Author

Guan-lin DI

Zhen-gang ZHU

Yan-long ZHEN

Yi-xue ZHEN

Kai-ming HUO

Hai-mei WENG

Yan WANG

LIANG Lyuyuan

Related Institution

First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

Sanya Hospital of Traditional Chinese Medicine

The Second Affiliated Hospital of Hainan Medical College

Hainan People's Hospital

Pediatric Hospital of the First Affiliated Hospital of Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰